InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Adelman Burt A, Director. Director active across 2 companies, notably Verve Therapeutics, Inc.. Aggregated, 8 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €325k. History available since 2 December 2021. The latest transaction was filed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Adelman Burt A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
428,326 sharesCommon StockSEC:0000950170-25-099258:0
10,000 shares@ US$12.152636.0% of flowCommon StockSEC:0000899243-22-018016:0
Canonical exit: 10 Aug 2022 (T+90)
4,000 shares@ US$21.383824.0% of flowCommon StockSEC:0000899243-22-011337:0
Canonical exit: 13 Jun 2022 (T+90)
4,700 shares@ US$31.341240.0% of flowCommon StockSEC:0000899243-21-046887:0
Canonical exit: 2 Mar 2022 (T+90)
208,602 sharesCommon StockSEC:0000908662-16-000425:0
140,268 sharesCommon StockSEC:0000908662-16-000393:0
1,458 sharesCommon StockSEC:0000908662-16-000393:1
1,251 sharesCommon StockSEC:0000908662-16-000393:2
8 of 8 declarations
About Adelman Burt A
ADELMAN BURT A is Administrateur. He has 8 filings in total, and across the sampled recent filings from 2016-01-15 to 2025-07-28, purchases total 325377 EUR and sales 0 EUR. The companies mentioned are Verve Therapeutics, Inc. and DYAX CORP.
